Cardiopulmonary Bypass Duration Is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 6, 2008, Pages 814-822

  Salis, Stefano ^a   Mazzanti, Valeria V ^a   Merli, Guido ^a   Salvi, Luca ^a   Tedesco, Calogero C ^a   Veglia, Fabrizio ^a   Sisillo, Erminio ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

cardiac surgery; cardiopulmonary bypass; postoperative complications

Indexed keywords

ATROPINE; FENTANYL; ISOFLURANE; MORPHINE; PANCURONIUM; PROPOFOL; SEVOFLURANE; SUFENTANIL; THIOPENTAL;

ANURIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; COMA; CONTINUOUS INFUSION; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; INTESTINE ISCHEMIA; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; OLIGURIA; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 56349156090     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.08.004     Document Type: Article

References (51)

1. Murphy G.J., and Angelini G.D. Side effects of cardiopulmonary bypass: What is the reality?. J Card Surg 19 (2004) 481-488
2. Cremer J., Martin M., Redl H., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (1996) 1714-1720
3. Kaza A.K., Cope J.T., Fiser S.M., et al. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg 75 (2003) 555-559
4. Jewell A.E., Akowuah E.F., Suvarna S.K., et al. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg 23 (2003) 633-636
5. Grigore A.M., Grocott H.P., Mathew J.P., et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 94 (2002) 4-10
6. Djaiani G., Fedorko L., Borger M., et al. Mild-to-moderate atheromatous disease of the thoracic aorta and new ischemic brain lesions after conventional coronary artery bypass graft surgery. Stroke 35 (2004) e356-e358
7. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Pract 10 suppl 2 (2004) 21-33
8. DeFoe G.R., Ross C.S., Olmstead E.M., et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 71 (2001) 769-776
9. Hazama S., Eishi K., Yamachika S., et al. Inflammatory response after coronary revascularization: Off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Ann Thorac Cardiovasc Surg 10 (2004) 90-96
10. Ascione R., Lloyd C.T., Underwood M.J., et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
11. Holcomb H.B., Stammers A.H., Gao C., et al. Perfusion treatment algorithm: Methods of improving the quality of perfusion. J Extra Corpor Technol 35 (2003) 290-296
12. Butler J., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
13. Day J.R., and Taylor K.M. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 3 (2005) 129-140
14. Ohata T., Mitsuno M., Yamamura M., et al. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution. ASAIO J 54 (2008) 207-209
15. Hunt B.J., Parratt R.N., Segal H.C., et al. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 65 (1998) 712-718
16. Moat N.E., Shore D.F., and Evans T.W. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 7 (1993) 563-573
17. Butler J., Parker D., Pillai R., et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 105 (1993) 25-30
18. Zimmermann A.K., Simon P., Seeburger J., et al. Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real-time PCR. J Cell Mol Med 7 (2003) 146-156
19. Weerasinghe A., and Taylor K.M. The platelet in cardiopulmonary bypass. Ann Thorac Surg 66 (1998) 2145-2252
20. Nakasuji M., Matsushita M., and Asada A. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass. J Anesth 19 (2005) 118-123
21. Palanzo D.A. Perfusion safety: Defining the problem. Perfusion 20 (2005) 195-203
22. Kirklin J.W. Open heart surgery at the Mayo Clinic. Mayo Clin Proc 55 (1980) 339-341
23. Taylor K.M. SIRS-The systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (1996) 1607-1608
24. Whitten C.W., Hill G.E., Ivy R., et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?. Anesth Analg 86 (1998) 28-33
25. Khabar K.S., elBarbary M.A., Khouqeer F., et al. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol 85 (1997) 97-103
26. Bucerius J., Gummert J.F., Borger M.A., et al. Stroke after cardiac surgery: A risk factor analysis of 16184 consecutive adult patients. Ann Thorac Surg 75 (2003) 472-478
27. Hogue Jr. C.W., Murphy S.F., Schechtman K.B., et al. Risk factors for early or delayed stroke after cardiac surgery. Circulation 100 (1999) 642-647
28. Schuller A.M., Windolf J., Blaheta R., et al. Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass. Biochem Biophys Res Commun 329 (2005) 616-623
29. Puskas F., Grocott H.P., White W.D., et al. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 84 (2007) 1467-1473
30. D'Ancona G., Baillot R., Poirier B., et al. Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30 (2003) 280-285
31. Ohri S.K., Bjarnason I., Pathi V., et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 55 (1993) 1080-1086
32. Kumle B., Boldt J., Suttner S.W., et al. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 75 (2003) 1558-1564
33. Andersson B., Nilsson J., Brandt J., et al. Gastrointestinal complications after cardiac surgery. Br J Surg 92 (2005) 326-333
34. Perugini R.A., Orr R.K., Porter D., et al. Gastrointestinal complications following cardiac surgery. An analysis of 1477 cardiac surgery patients. Arch Surg 132 (1997) 352-357
35. Christenson J.T., Schmuziger M., Maurice J., et al. Gastrointestinal complications after coronary artery bypass grafting. J Thorac Cardiovasc Surg 108 (1994) 899-906
36. Khuri S.F., Wolfe J.A., Josa M., et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 104 (1992) 94-107
37. Parr K.G., Patel M.A., Dekker R., et al. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 17 (2003) 176-181
38. Despotis G.J., Filos K.S., Zoys T.N., et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg 82 (1996) 13-21
39. Zilla P., Fasol R., Groscurth P., et al. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 97 (1989) 379-388
40. Wahba A., Rothe G., Lodes H., et al. Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery. Thromb Res 97 (2000) 379-386
41. Slaughter T.F., LeBleu T.H., Douglas Jr. J.M., et al. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 80 (1994) 520-526
42. Blauhut B., Harringer W., Bettelheim P., et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 108 (1994) 1083-1091
43. Naughton C., Reilly N., Powroznyk A., et al. Factors determining the duration of tracheal intubation in cardiac surgery: A single-centre sequential patient audit. Eur J Anaesthesiol 20 (2003) 225-233
44. Canver C.C., and Chanda J. Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg 75 (2003) 853-857
45. Sinclair D.G., Haslam P.L., Quinlan G.J., et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest 108 (1995) 718-724
46. Görlach G., Sroka J., Heidt M., et al. Intracellular adhesion molecule-1 in patients developing pulmonary insufficiency after cardiopulmonary bypass. Thorac Cardiovasc Surg 51 (2003) 138-141
47. Tönz M., Mihaljevic T., von Segesser L.K., et al. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible?. Chest 108 (1995) 1551-1556
48. Milot J., Perron J., Lacasse Y., et al. Incidence and predictors of ARDS after cardiac surgery. Chest 119 (2001) 884-888
49. Dimopoulou I., Daganou M., Dafni U., et al. Phrenic nerve dysfunction after cardiac operations: Electrophysiologic evaluation of risk factors. Chest 113 (1998) 8-14
50. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128 (1998) 194-203
51. Andersson L.G., Bratteby L.E., Ekroth R., et al. Renal function during cardiopulmonary bypass: Influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 8 (1994) 597-602